Table 1.
Lifetime | 6-Month |
30-Day |
|||
---|---|---|---|---|---|
N (%) | N (%) | Median # days useda |
N (%) | Median # of days useda |
|
Drug use prevalenceb | 115 (84.6) | 64 (47.1) | – | 46 (33.8) | – |
Cannabis | 104 (76.5) | 35 (25.7) | 7 | 22 (16.2) | 4 |
Cocaine | 63 (46.3) | 28 (20.6) | 22.5 | 16 (11.8) | 4 |
Heroin and other opiates | 49 (36.0) | 24 (17.6) | 19.5 | 18 (13.2) | 3.5 |
Sedatives, hypnotics, tranquilizers | 20 (14.7) | 12 (8.8) | 29 | 10 (7.4) | 22.5 |
Alcohol use prevalence | 122 (89.7) | 85 (62.5) | 14 | 70 (51.5) | 3.5 |
Used to intoxication prevalencec | – | 69 (50.7) | 12 | 53 (39.0) | 3 |
Median number of days used reported only for women reporting to have used respective drug during past 6-month or 30-day time period; Note: number of days was asked with respect to each drug rather than any drug use, therefore number of mean days for 6-month or 30-day drug use reported for specific drugs and not any drug use
Prevalence and frequency of hallucinogens, amphetamines, barbiturates, and inhalants not reported as less than 5% of sample used these drugs during the past 6-months
Participants were not asked about lifetime alcohol use to intoxication